{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:02:59Z","timestamp":1785358979137,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijgc.2026.104730","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:13:34Z","timestamp":1777580014000},"page":"104730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of apixaban versus enoxaparin in gynecologic oncology surgery: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-090X","authenticated-orcid":false,"given":"Sarah","family":"Al-Rubaish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2674-1070","authenticated-orcid":false,"given":"Ayman","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4041-3591","authenticated-orcid":false,"given":"Wala","family":"Mehros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas","family":"Mutahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Attia","family":"Elfadali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijgc.2026.104730_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/healthcare8010048","article-title":"Predictive factors of deep vein thrombosis in gynecologic cancer survivors with lower extremity edema: a single-center and retrospective study","volume":"8","author":"Kim","year":"2020","journal-title":"Healthcare (Basel)"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104730_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3892\/mco.2022.2541","article-title":"Incidence and risk factors of perioperative venous thromboembolism in patients with cervical cancer","volume":"16","author":"Zhao","year":"2022","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ijgc.2026.104730_bib3","series-title":"Venous thromboembolism in gynecologic surgery","author":"Clarke-Pearson","year":"2008"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104730_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2010.11.038","article-title":"Incidence and timing of venous thromboembolism after surgery for gynecological cancer","volume":"121","author":"Peedicayil","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104730_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jmig.2013.06.001","article-title":"Venous thromboembolic events in minimally invasive gynecologic surgery","volume":"20","author":"Ramirez","year":"2013","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104730_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4274\/imj.galenos.2023.86143","article-title":"Incidence and risk factors of venous thromboembolism in patients undergoing surgery for gynecologic malignancies","volume":"24","author":"Turan","year":"2023","journal-title":"Istanbul Med J"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104730_bib7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s40262-019-00775-z","article-title":"Apixaban: A clinical pharmacokinetic and pharmacodynamic review","volume":"58","author":"Byon","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijgc.2026.104730_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3332\/ecancer.2020.1091","article-title":"Assessing the benefits and harms of direct oral anticoagulants in patients with cancer for the prophylaxis and treatment of venous thromboembolism: a systematic review and meta-analysis","volume":"14","author":"Desai","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104730_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaccao.2020.06.001","article-title":"Direct oral anticoagulants in patients with active cancer: a systematic review and meta-analysis","volume":"2","author":"Sabatino","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104730_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7410","article-title":"Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial","volume":"3","author":"Guntupalli","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijgc.2026.104730_bib12","article-title":"Apixaban versus enoxaparin to prevent venous thromboembolism in post-operative patients with gynecologic cancers at an urban academic medical center","volume":"56","author":"Diamond","year":"2024","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ijgc.2026.104730_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2024.01.039","article-title":"Efficacy, safety, and feasibility of apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center","volume":"183","author":"Knisely","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104730_bib14","article-title":"Efficacy of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after gynecological cancer surgery: a systematic review and meta-analysis","volume":"51","author":"Reis","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"suppl 1","key":"10.1016\/j.ijgc.2026.104730_bib15","article-title":"Thromboprophylaxis by direct oral anticoagulants versus low molecular weight heparin in patients undergoing surgery for gynecological cancer: a systematic review and meta-analysis","volume":"144","author":"Dave","year":"2024","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104730_bib16","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3390\/cancers14102439","article-title":"A systematic review of the guidelines on venous thromboembolism prophylaxis in gynecologic oncology","volume":"14","author":"Romano","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104730_bib17","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1002\/onco.13596","article-title":"Update on guidelines for the management of cancer-associated thrombosis","volume":"26","author":"Streiff","year":"2021","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104730_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2021.01.027","article-title":"Prevention of venous thromboembolism in gynecological cancer patients undergoing major abdominopelvic surgery: a systematic review and network meta-analysis","volume":"161","author":"Insin","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104730_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ijgc.2026.104730_bib20","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ijgc.2026.104730_bib21","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"7818","key":"10.1016\/j.ijgc.2026.104730_bib22","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad","year":"2024","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.ijgc.2026.104730_bib23","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijgc.2026.104730_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2023.02.012","article-title":"Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy","volume":"172","author":"Sp\u00e9nard","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2026.104730_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/10760296251372947","article-title":"Efficacy of factor Xa inhibitors versus placebo in thromboprophylaxis for cancer-associated thromboembolism: a systematic review and meta-analysis","volume":"31","author":"Kamil","year":"2025","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104730_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/0118715257331706240919172310","article-title":"Factor Xa inhibitors and low molecular weight heparins in perioperative surgical thromboprophylaxis: a network meta-analysis","volume":"23","author":"Bajpai","year":"2025","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.ijgc.2026.104730_bib27","article-title":"Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: a quality mini-review","volume":"56","author":"Ketch","year":"2024","journal-title":"Gynecol Oncol Rep"},{"issue":"16","key":"10.1016\/j.ijgc.2026.104730_bib28","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:23:01Z","timestamp":1785356581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26002616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1048891X26002616"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104730","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of apixaban versus enoxaparin in gynecologic oncology surgery: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104730"}}